The influenza virus (IV) is known to be a resistant virus with frequent mutations, causing severe respiratory diseases in the upper respiratory system. Public health concerns about clinical efficacy of all conventional drugs are ambiguous; therefore, finding additional therapeutic agents is critical to prevent and control influenza outbreaks. Influenza is associated with the induction of proinflammatory cytokines. Scientists have reported that anti-inflammatory drugs, with pleiotropic effects, reduce the burden of severe influenza diseases. Therefore, statins, which are cardioprotective drugs with anti-inflammatory and immunomodulatory effects, may help patients suffering from influenza virus (IV). This review delineates the potential use o...
The influenza virus (IV) is a highly contagious virus causing seasonal global outbreaks affecting an...
The influenza virus (IV) is a highly contagious virus causing seasonal global outbreaks affecting an...
HMG-CoA reductase inhibitors such as rosuvastatin may have immunomodulatory and anti-inflammatory ef...
Copyright © 2014 Parvaneh Mehrbod et al. This is an open access article distributed under the Creati...
The next influenza pandemic may be imminent. Because antiviral agents and vaccines will be unavailab...
Influenza virus infection still remains a major cause of morbidity and mortality Recently, to lessen...
The COVID-19 pandemic has had a huge impact on the health of millions of people around the world on ...
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objectiv...
The high mortality of highly pathogenic avian influenza A (H5N1) viruses infection in humans gives r...
Influenza A virus is one of the most important health risks that lead to significant respiratory inf...
Statins possess immunomodulatory properties and have been proposed for reducing morbidity during an ...
Influenza viruses represent a leading cause of high morbidity and mortality worldwide. Approaches fo...
Influenza viruses represent a leading cause of high morbidity and mortality worldwide. Approaches fo...
Influenza is an acute respiratory disease caused by the flu virus. The influenza virus is a RNA-cont...
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has...
The influenza virus (IV) is a highly contagious virus causing seasonal global outbreaks affecting an...
The influenza virus (IV) is a highly contagious virus causing seasonal global outbreaks affecting an...
HMG-CoA reductase inhibitors such as rosuvastatin may have immunomodulatory and anti-inflammatory ef...
Copyright © 2014 Parvaneh Mehrbod et al. This is an open access article distributed under the Creati...
The next influenza pandemic may be imminent. Because antiviral agents and vaccines will be unavailab...
Influenza virus infection still remains a major cause of morbidity and mortality Recently, to lessen...
The COVID-19 pandemic has had a huge impact on the health of millions of people around the world on ...
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objectiv...
The high mortality of highly pathogenic avian influenza A (H5N1) viruses infection in humans gives r...
Influenza A virus is one of the most important health risks that lead to significant respiratory inf...
Statins possess immunomodulatory properties and have been proposed for reducing morbidity during an ...
Influenza viruses represent a leading cause of high morbidity and mortality worldwide. Approaches fo...
Influenza viruses represent a leading cause of high morbidity and mortality worldwide. Approaches fo...
Influenza is an acute respiratory disease caused by the flu virus. The influenza virus is a RNA-cont...
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has...
The influenza virus (IV) is a highly contagious virus causing seasonal global outbreaks affecting an...
The influenza virus (IV) is a highly contagious virus causing seasonal global outbreaks affecting an...
HMG-CoA reductase inhibitors such as rosuvastatin may have immunomodulatory and anti-inflammatory ef...